Antimicrobial activities of some synthesized 1-(3-(2-methylphenyl)-4-Oxo-3H-quinazolin-2-yl-4-(substituted)thiosemicarbazide derivatives


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The substituted thiosemicarbazide moiety was placed at the C-2 position and 2-methylphenyl group at N-3 position of quinazoline ring and obtained compounds were tested for their antitubercular activities and antibacterial activities against selected gram-positive and gram-negative bacteria. The target compounds 1-(3-(2-methylphenyl)-4-oxo-3H-quinazolin-2-yl)-4-(substituted) thiosemicarbazides were obtained by the reaction of 2-hydrazino-3-(2-methylphenyl) quinazolin-4(3H)-one with different dithiocarbamic acid methyl ester derivatives. All synthesized compounds were also screened for their antimicrobial activity against selective gram-positive and gram-negative bacteria by agar dilution method. Among the series, 1-[3-(2-methylphenyl)-4-oxo-3H-quinazolin-2-yl]-4-[4-chlorophenyl]-thiosemicarbazide exhibited the most potent activity against S. typhi, E. coli, and B. subtilis, while 1-[3-(2-methylphenyl)-4-oxo-3H-quinazolin-2-yl]-4-[4-nitrophenyl]-thiosemicarbazide was the most potent against E. coli, B. subtilis, P. aeruginosa, S. typhi, and S. flexneri. These two compounds exhibited the antitubercular activity at the minimum concentration (3 μg/mL) that offered potential for further optimization and development of new antitubercular agents. The obtained results demonstrated promising antimicrobial and antitubercular activities of the synthesized quinazoline compounds which could be used as new scaffolds for improving their antimicrobial activity.

Sobre autores

V. Alagarsamy

Medicinal Chemistry Research Laboratory

Autor responsável pela correspondência
Email: drvalagarsamy@gmail.com
Índia, Gr. Hyderabad, 502294

G. Anjana

Department of Pharmaceutical Chemistry

Email: drvalagarsamy@gmail.com
Índia, Thiruvananthapuram, 695575

M. Sulthana

Medicinal Chemistry Research Laboratory

Email: drvalagarsamy@gmail.com
Índia, Gr. Hyderabad, 502294

P. Parthiban

Medicinal Chemistry Research Laboratory

Email: drvalagarsamy@gmail.com
Índia, Gr. Hyderabad, 502294

V. Solomon

Medicinal Chemistry Research Laboratory; Faculty of Pharmacy, the University of Sydney

Email: drvalagarsamy@gmail.com
Índia, Gr. Hyderabad, 502294; Sydney, NSW, 2006


Declaração de direitos autorais © Pleiades Publishing, Ltd., 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies